Marker Therapeutics (MRKR) Divestments (2022 - 2023)

Marker Therapeutics (MRKR) reported Divestments of $18.8 million for Q2 2023, up 16774.42% quarter-over-quarter from -$112608.0 in Q1 2023.

Marker Therapeutics (MRKR) Divestments (2022 - 2023) Analysis & Trends

Marker Therapeutics (MRKR) has 2 years of Divestments data on file, last reported at $18.8 million in Q2 2023.

Divestments for Q2 2023 came in at $18.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $18.7 million (changed N/A YoY), and the FY2023 annual result was $18.7 million, up 477.42% from the prior year.
Divestments climbed to $18.8 million in Q2 2023 per MRKR's latest filing, from -$112608.0 in the prior quarter.
Over five years, Divestments peaked at $18.8 million in Q2 2023 and troughed at -$127342.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Marker Therapeutics	28.20 Mn	28.20 Mn	-	-

Download Data